Anavex Life Sciences Reports Promising Results for Alzheimer’s Treatment
Anavex Life Sciences has announced promising outcomes from a recent phase 2b/3 trial of their investigational drug, blarcamesine (ANAVEX®2-73). Conducted across multiple centers, the trial […]